Medical Crossfire®: Turning Therapeutic Innovation Into Practice—Personalizing Care in Multiple Myeloma

Overview:

Despite major advances, multiple myeloma (MM) remains a biologically complex malignancy requiring increasingly nuanced treatment decisions. The rapid expansion of quadruplet frontline regimens, MRD-guided strategies, and T-cell–redirecting therapies has improved outcomes but created uncertainty around sequencing, patient selection, and toxicity management. Clinicians must balance evolving genomic risk stratification, emerging trial data, and real-world patient factors to personalize care across the disease continuum.

Medical Crossfire®: Turning Therapeutic Innovation Into Practice—Personalizing Care in Multiple Myeloma, held in conjunction with the World Congress on Controversies in Multiple Myeloma (COMy), will feature an interactive, debate-driven discussion among leading experts. Through real-world cases, focused data reviews, and audience polling, faculty will examine frontline quadruplet therapy, administration considerations for therapy and optimal sequencing of CART, bispecific and ADC therapies for their patients. This dynamic format will equip clinicians with practical strategies to translate emerging evidence into individualized treatment plans for patients with MM.

Learning Objectives:

Upon completion of this activity, learners will be better able to:

• Evaluate recent efficacy and safety data from pivotal trials assessing new and emerging therapies for MM
• Apply disease-specific and individual patient considerations to optimize personalized treatment planning in MM
• Assess the evolving evidence on using MRD assessments to guide the choice and duration of maintenance therapy
• Implement the latest best practices for preventing and managing treatment-related toxicities in patients with MM

Target Audience:

This educational activity is directed toward hematologist-oncologists, advanced practice providers, nurses, pharmacists, and other health care providers involved in the diagnosis and treatment of multiple myeloma.

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.25 Contact Hours.

Medical Oncologists (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

European Board for Accreditation in Hematology (EBAH)

Medical Crossfire^®: Turning Therapeutic Innovation Into Practice—Personalizing Care in Multiple Myeloma has been reviewed and approved for CME-CPD accreditation by the European Board for Accreditation in Hematology (EBAH). The EBAH has approved this educational activity for a maximum number of 1 CME-CPD credits. Each participant should only collect credits for time that she/he actually spent in the educational activity.

How to collect your EBAH CME credits:

You can also use the direct link to the account creation / login page:

1. Creating a CME account or log in is simple and free of cost
2. Please provide your details to the event organizer, so they can add your EBAH-CME credit points.

Within the EBAH-CME system, you can:

• Print your EBAH-CME certificates.
• Review and manage your personal account.
• Search for accredited events based on the European Hematology Curriculum.

For further assistance please contact: EBAH

Email: [email protected]